Global laparoscopic devices (incl. MIS robotic systems) will grow from $21B in 2025 to ~$37B by 2031, driven by ...

Global medical technology firm with diversified therapeutic portfolio Strong institutional backing reflects broad market ...

Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

Irish medtech giant Medtronic has secured another US approval for its OmniaSecure defibrillation lead, expanding its use to ...

Medtronic strengthens neurovascular segment with advanced guidewire technologies; Scientia Vascular enhances complex stroke ...

By Sahil Pandey March 10 (Reuters) - Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular ...

Medtronic (NYSE: MDT) made a significant neurovascular play earlier this month when it agreed to acquire Scientia Vascular.

David Dinsmoor, the local Medtronic engineer who worked on Inceptiv Medtronic researchers say a recently approved closed-loop spinal cord stimulator marks one of the company’s biggest breakthroughs in ...

One of the biggest growth stories in medical devices is Intuitive Surgical, but don't overlook the opportunity ahead for this competitor.

Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...

Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps with ...

WASHINGTON, March 10 (Reuters) - Medtronic Inc missed the main effectiveness goal in a study testing an approved brain device for treatment of epilepsy, U.S. device reviewers said in documents ...